LM-168 Clinical Trials

2 actively recruiting trials

▲ +1 trial since July 2026

Pipeline

Phase 2: 1Phase 1/2: 1

Top Sponsors

LaNova Medicines Limited2

Indications

Cancer2
Advanced Solid Tumours1
Advanced Solid Tumor1

Other2 trials

A Study of LM-168 Combined With Other Anti-tumor Treatments in Participants With Advanced Solid Tumors

Phase 2

A Study of LM-168 as a Single Agent or in Combination With Toripalimab in Subjects With Advanced Solid Tumours

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.